News

Filter

Current filters:

ImmunologicalsDiabetes

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal

23-04-2013

Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Lilly gains global rights to Incyte's novel JAK1/JAK2 inhibitor for $90 million upfront and up to $665 million more; deal with PDL

22-12-2009

US firm Incyte saw its shares rise 5% to $8.92 after announcing it had entered into an exclusive worldwide…

Anti-Arthritics/RheumaticsDiabetesImmunologicalsLicensingLillyNystatinOralPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top